Sleep apnea is a full blown epidemic - more than 29.4 million Americans are estimated to suffer from moderate to severe OSA - but strikingly, 80% of those individuals
are living unaware and undiagnosed. If left untreated, sleep apnea can lead to severe complications including high blood pressure, chronic heart failure, atrial fibrillation, stroke, metabolic syndromes, drowsy driving, and is estimated to double a patients healthcare costs.
In order to address this epidemic, we have to increase the efficiency of sleep studies and scale sleep medicine.
Our mission at EnsoData is to build
accurate and reliable tools that make this possible, enabling more patients to access the healthcare they need every day.